Structure/activity relationships of M2 muscarinic allosteric modulators

Receptors and Channels

Volumn 9, Issue 4, 2003, Pages 229-240

  Mohr, K ^a   Trankle C ^a   Holzgrabe, U ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Allosteric modulators; M2 subtype; Muscarinic receptors; Review; SARs

Indexed keywords

ACETYLCHOLINE; ADENOSINE A1 RECEPTOR; ALCURONIUM; ALKALOID DERIVATIVE; ALKANE DERIVATIVE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR; BRUCINE; CHOLINERGIC RECEPTOR AFFECTING AGENT; G PROTEIN COUPLED RECEPTOR; GALLAMINE; HISTAMINE H1 RECEPTOR; LIGAND; METHYLSCOPOLAMINE; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROMUSCULAR BLOCKING AGENT; PRAZOSIN; QUINUCLIDINYL BENZILATE; RECEPTOR SUBTYPE; STAUROSPORINE; STRYCHNINE; UNINDEXED DRUG; VINBURNINE; VINCAMINE;

ALLOSTERISM; BINDING AFFINITY; BINDING SITE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG SELECTIVITY; LIGAND BINDING; MODULATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ALCURONIUM; ALKANES; ALLOSTERIC REGULATION; ANIMALS; HUMANS; RECEPTOR, MUSCARINIC M2; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

STRYCHNOS TOXIFERA;

EID: 0041912480     PISSN: 10606823     EISSN: None     Source Type: Journal    
DOI: 10.1080/10606820308264     Document Type: Review

References (88)

1. Bejeuhr, G., Holzgrabe, U., Mohr, K., Sürig, U., and von Petersenn, A. 1992. Pharm. Pharmacol. Lett. 2:100-103.
2. Bender, W., Staudt, M., Tränkle, C., Mohr, K., and Holzgrabe, U. 2000. Life Sci. 66:1675-1682.
3. Berlage, F., Bernauer, K., von Philipsborn, W., Waser, P., Schmidt, H., and Karrer, P. 1959. Helv. Chim. Acta 42:394-397.
4. Birdsall, N. J., Lazareno, S., and Matsui, H. 1996. Prog. Brain Res. 109:147-151.
5. Botero Cid, H. M., Holzgrabe, U., Kostenis, E., Mohr, K., and Tränkle, C. 1994. J. Med. Chem. 37:1439-1445.
6. Botero Cid, H. M., Tränkle, C., Baumann, K., Pick, R., Mies-Klomfass, E., Kostenis, E., Mohr, K., and Holzgrabe, U. 2000. J. Med. Chem. 43:2155-2164.
7. Bradley, K. N., Rowan, E. G., and Harvey, A. L. 2001. Toxicon. 39:581-587.
8. Buller, S., Zlotos, D. P., Mohr, K., and Ellis, J. 2002. Mol. Pharmacol. 61:160-168.
9. Choo, L. K., and Mitchelson, F. 1989. Eur. J. Pharmacol. 162:429-435.
10. Christopoulos, A. 2002. Nature Rev. Drug Discov. 1:198-210.
11. Christopoulos, A., Lanzafame, A., and Mitchelson, F. 1998. Clin. Exp. Pharmacol. Physiol. 25:185-194.
12. Christopoulos, A., Loiacono, R., and Mitchelson. 1993. Eur. J. Pharmacol. 246:1-8.
13. Christopoulos, A., and Mitchelson, F. 1994. Mol. Pharmacol. 46:105-114.
14. Christopoulos, A., Sorman, J. L., Mitchelson, F., and El-Fakahany, E. E. 1999. Biochem. Pharmacol. 57:171-179.
15. Clark, A. L., and Mitchelson, F. 1976. Br. J. Pharmacol. 58:323-331.
16. Daiss, J. O., Duda-Johner, S., Burschka, C., Holzgrabe, U., Mohr, K., and Tacke, R. 2002. Organometallics 21:803-811.
17. Ehlert, F. J. 1988. Mol. Pharmacol. 35:187-194.
18. Ellis, J. 1997. Drug. Dev. Res. 40:193-204.
19. Ellis, J., Huyler, J., and Brann, M. R. 1991. Biochem. Pharmacol. 42:1927-1932.
20. Ellis, J., and Seidenberg. 1989. Mol. Pharmacol. 35:173-176.
21. Ellis, J., and Seidenberg, M. 1992. Mol. Pharmacol. 42:638-641.
22. Ellis, J., and Seidenberg, M. 2000. Mol. Pharmacol. 58:1451-1460.
23. Flügel, M., Tränkle, C., Holzgrabe, U., and Mohr, K. 2000. Naunyn-Schmiedeberg's Arch. Pharmacol. 361:R24 (abstract).
24. Franken, C., Tränkle, C., and Mohr, K. 2000. Naunyn-Schmiedeberg's Arch. Pharmacol. 361:107-112.
25. Gao, Z., and Liu, C. 1995. Eur. J. Pharmacol. 289:369-373.
26. Gerry, R. H., Rauch, B., Covin, R. A., Adler, P. N., and Messineo, F. C. 1987. Biochem. Pharmacol. 36:2951-2956.
27. Gharagozloo, P., Lazareno, S., Popham, A., and Birdsall, N. J. M. 1999. J. Med. Chem. 42:438-445.
28. Gilani, A. H., Shaheen, F., Christopoulos, A., and Mitchelson, F. 1997. Life Sci. 60:535-544.
29. Girke, S., Mohr, K., and Schrape, S. 1989. Biochem. Pharmacol. 38:2487-2496.
30. Gnagey, A. L., Seidenberg, M., and Ellis, J. 1999. Mol. Pharmacol. 56:1245-1253.
31. Heber, D., Mohr, K., and Ohnesorge, H. 1991. Naunyn-Schmiedeberg's Arch. 343:R90 (abstract).
32. Hejnová, L., Tuček, S., and El-Fakahany, E. E. 1995. Eur. J. Pharmacol. 291:427-430.
33. Holzgrabe, U., and Hopfinger, A. J. 1996. J. Chem. Inf. Comput. Sci. 36:1018-1024.
34. Holzgrabe, U., and Mohr, K. 1998. Drug Discovery Today 3:214-222.
35. Holzgrabe, U., Wagener, M., and Gasteiger, J. 1996. J. Mol. Graph. 14:185-193.
36. Jakubík, J., Bačáková, L., El-Fakahany, E. E., and Tuček, S. 1995. J. Pharmacol. Exp. Ther. 274:1077-1083.
37. Jakubík, J., Bačáková, L., El-Fakahany, E. E., and Tuček, S. 1997. Mol. Pharmacol. 52:172-179.
38. Jakubík, J., and Tuček, S. 1994. J. Neurochem. 63:1932-1940.
39. Jakubík, J., and Tuček, S. 1995. Eur. J. Pharmacol. 289:311-319.
40. Jepsen, K., Mohr, K., Lüllmann, H., and Pfeffer, J. 1988. Pharmacol. Toxicol. 63:163-168.
41. Johner, S., Pick, R., Buller, S., Tränkle, C., Holzgrabe, U., and Mohr, K. 1999. Arch. Pharm. Pharm. Med. Chem. 331:69 (abstract).
42. Klein, C. D., Tabeteh, G. F., Laguna, A. V., Holzgrabe, U., and Mohr, K. 2001. Eur. J. Pharm. Sci. 14:167-175.
43. Kords, H., Lüllmann, H., Ohnesorge, F. K., and Wassermann, O. 1968. Eur. J. Pharmacol. 3:341-346.
44. Kostenis, E., Botero Cid, H. M., Holzgrabe, U., and Mohr, K. 1996. Eur. J. Pharmacol. 314:385-392.
45. Kostenis, E., Holzgrabe, U., and Mohr, K. 1994. Eur. J. Med. Chem. 29:947-953.
46. Kostenis, E., and Mohr, K. 1996. Trends Pharmacol. Sci. 17:443-444.
47. Lanzafame, A., Christopoulos, A., and Mitchelson, F. 1996. Eur. J. Pharmacol. 316:27-32.
48. Lanzafame, A., Christopoulos, A., and Mitchelson, F. 1997. J. Pharmacol. Exp. Ther. 282:278-285.
49. Lazareno, S., and Birdsall, N. J. M. 1995. Mol. Pharmacol. 48:362-378.
50. Lazareno, S., Birdsall, B., Fukazawa, T., Gharagozloo, P., Hashimoto, T., Kuwano, H., Popham, A., Sugimoto, M., and Birdsall, N. J. M. 1999. Life Sci. 64:519-526.
51. Lazareno, S., Gharagozloo, P., Kuonen, D., Popham, A., and Birdsall, N. J. M. 1998. Mol. Pharmacol. 53:573-589.
52. Lazareno, S., Popham, A., and Birdsall, N. J. M. 2000. Mol. Pharmacol. 58:194-207.
53. Lee, N. H., and El-Fakahany, E. E. 1988. J. Pharmacol. Exp. Ther. 246:829-838.
54. Leppik, R. A., Miller, R. C., Eck, M., and Paquet, P. L. 1994. Mol. Pharmacol. 45:983-990.
55. Li, R., Tränkle, C., Mohr, K., and Holzgrabe, U. 2001. Arch. Pharm. Pharm. Med. Chem. 334:121-124.
56. Lüllmann, H., Ohnesorge, F. K., Schauwecker, G. C., and Wassermann, O. 1969. Eur. J. Pharmacol. 6:241-247.
57. Lysíková, M., Fuksová, K., Elbert, T., Jakubík, J., and Tuček, S. 1999. Brit. J. Pharmacol. 126:1240-1246.
58. Lysíková, M., ZdenÏk, H., and Tuček, S. 2001. Neurochem. Res. 26:383-394.
59. Maaß, A., and Mohr, K. 1996. Eur. J. Pharmacol. 305:231-234.
60. Mieskes, A. 1999. Untersuchung der Adsorption allosterischer Modulatoren von Muskarinrezeptoren an negativ geladene Interphasen. PhD-thesis University of Bonn.
61. 2. PhD-thesis University of Bonn.
62. Mitchelson, F. 1975. Eur. J. Pharmacol. 33:237-246.
63. Muth, M., Bender, W., Scharfenstein, O., Holzgrabe, U., Balatková, E., Tränkle, C., and Mohr, K. 2003. J. Med. Chem. 46:1031-1040.
64. Nassif-Makki, T., Tränkle, C., Zlotos, D., Bejeuhr, G., Cambareri, A., Kostenis, E., Mohr, K., and Holzgrabe, U. 1999. J. Med. Chem. 42:849-858.
65. Pfaffendorf, M., Batink, H. D., Tränkle, C., Mohr, K., and van Zwieten, P. A. 2000. J. Auton. Pharmacol. 20:55-62.
66. Proška, J., and Tuček, S. 1994. Mol. Pharmacol. 45:709-717.
67. Proška, J., and Tuček, S. 1996. Eur. J. Pharmacol. 305:201-205.
68. Raasch, A., Scharfenstein, O., Tränkle, C., Holzgrabe, U., and Mohr, K. 2001. Naunyn-Schmiedeberg's Arch. Pharmacol. 363:R24 (abstract).
69. Raasch, A., Scharfenstein, O., Tränkle, C., Holzgrabe, U., and Mohr, K. 2002. J. Med. Chem. 45:3809-3812.
70. Schröter, A., Tränkle, C., and Mohr, K. 2000. Naunyn-Schmiedeberg's Arch. Pharmacol. 362:512-519.
71. Staudt, M., Tränkle, C., Mohr, K., and Holzgrabe, U. 1998. Life Sci. 62:423-429.
72. Stockton, J. M., Birdsall, N. J. M., Burgen, A. S. V., and Hulme, E. C. 1983. Mol. Pharmacol. 23:551-557.
73. Tränkle, C., Andresen, I., Lambrecht, G., and Mohr, K. 1998. Mol. Pharmacol. 53:340-342.
74. Tränkle, C., Holzgrabe, U., and Mohr, K. 1998. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:R85 (abstract).
75. Tränkle, C., Kostenis, E., Burgmer, U., and Mohr, K. 1996. J. Pharmacol. Exp. Ther. 279:929-933.
76. Tränkle, C., Mies-Klomfaß, E., Botero Cid, H. M., Holzgrabe, U., and Mohr, K. 1998. Mol. Pharmacol. 54:139-145.
77. Tränkle, C., and Mohr, K. 1997. Mol. Pharmacol. 51:674-682.
78. Tränkle, C., Weyand, O., Schöter, A., and Mohr, K. 1999. Mol. Pharmacol. 56:962-965.
79. Tränkle, C., Weyand, O., Voigtländer, U., Mynett, A., Lazareno, L., Birdsall, N. J. M., and Mohr, K. 2003. Mol. Pharmacol. 64 (in press).
80. Tuček, S., Musílkova, J., Nedoma, J., Proška, J., Shelkovnikov, S., and Vorlíček, J. 1990. Mol. Pharmacol. 38:674-680.
81. Tuček, S., and Proška, J. 1995. Trends. Pharmacol. Sci. 16:205-212.
82. Urbanský, M., Proška, J., and Drašar, P. 1999. Cellect. Czech. Chem. Commun. 64:1457-1470.
83. Urbanský, M., Proška, J., Říčný, J., and Dršar, P. 1999. Cellect. Czech. Chem. Commun. 64:1980-1992.
84. Voigtländer, U., Jöhren, K., Mohr, M., Raasch, A., Tränkle, C., Buller, S., Ellis, J., Höltje, H.-D., and Mohr, K. 2003. Mol. Pharmacol. 64 (in press).
85. Waelbroeck, M. 1994. Mol. Pharmacol. 46:685-693.
86. Zahn, K., Eckstein, N., Tränkle, C., Sadee, W., and Mohr, K. 2002. J. Pharmacol. Exp. Ther. 301:720-728.
87. Zlotos, D. P. 2000. J. Nat. Prod. 63:864-865.
88. Zlotos, D. P., Buller, S., Tränkle, C., and Mohr, K. 2000. Bioorg. Med. Chem. Lett. 10:2529-2532.